Fangzheng Securities: MIRXES-B (02629.HK) is given a "buy" rating for the first time, and GASTROClear is approved for listing.

According to the Zhixin Finance and Economics APP, Fangzheng Securities released a research report stating that MIRXES-B (02629.HK) was officially included in the Hang Seng Composite Index and the Hong Kong Stock Connect on September 8, 2025. Considering its unique technical scarcity and the huge growth potential in the Chinese market, it is expected to attract a significant amount of southbound funds attention and allocation, bringing additional upward momentum to the company's stock price. The bank expects the company's revenue to be $27 million, $41 million, and $75 million in 2025, 2026, and 2027, respectively, with year-on-year growth rates of 30.84%, 55.14%, and 81.32%. First coverage, with a "recommended" rating.